BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tzouvala M, Zacharopoulou E, Kalafateli M, Viazis N, Psistakis A, Theodoropoulou A, Drygiannakis I, Karmiris K, Koutroubakis IE, Kevrekidou P, Soufleris K, Katsaros M, Giouleme O, Fousekis F, Katsanos K, Christodoulou D, Gaki A, Papathanasiou E, Bamias G, Zampeli E, Michopoulos S, Kyriakos N, Veretanos C, Argyriou K, Kapsoritakis A, Tribonias G, Mantzaris GJ, Liatsos C. Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up study. World J Gastroenterol 2025; 31(42): 111282 [PMID: 41278164 DOI: 10.3748/wjg.v31.i42.111282]
URL: https://www.wjgnet.com/1007-9327/full/v31/i42/111282.htm
Number Citing Articles
1
Ahmed S Aboelela, Yasser Fouad. Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitisWorld Journal of Gastroenterology 2026; 32(9): 115785 doi: 10.3748/wjg.v32.i9.115785